Where does MBX Biosciences, Inc.'s income statement data come from?

Every line is extracted from MBX Biosciences, Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.

	Q1 '26	Q4 '25	Q3 '25	Q2 '25	Q1 '25
Research and development	$18.47M-6.5%	$19.76M+2.5%	$19.27M+8.7%	$17.72M-20.9%	$22.41M+47.2%
General and administrative	$8.79M+45.6%	$6.04M+29.6%	$4.66M+14.1%	$4.08M-1.0%	$4.12M+21.8%
Other operating expenses	$27.27M+5.7%	$25.8M+7.8%	$23.93M+9.7%	$21.81M-17.8%	$26.53M+42.6%
Total operating expenses	$27.27M+5.7%	$25.8M+7.8%	$23.93M+9.7%	$21.81M-17.8%	$26.53M+42.6%
Operating income	-$27.27M-5.7%	-$25.8M-7.8%	-$23.93M-9.7%	-$21.81M+17.8%	-$26.53M-42.6%
Interest income	$3.75M+0.4%	$3.73M+61.7%	$2.31M-3.6%	$2.39M-9.6%	$2.65M-12.4%
Net income	-$23.52M-6.5%	-$22.09M-2.2%	-$21.62M-11.4%	-$19.41M+18.7%	-$23.88M-53.2%
Diluted earnings per share	-$0.50-11.1%	-$0.45+28.6%	-$0.63-8.6%	-$0.58+18.3%	-$0.71—
Basic earnings per share	-$0.50-11.1%	-$0.45+28.6%	-$0.63-8.6%	-$0.58+18.3%	-$0.71—
Weighted-average shares, diluted	46.6M+27.6%	36.5M+6.7%	34.2M+2.2%	33.4M+0.1%	33.4M+214%
Weighted-average shares, basic	46.6M+27.6%	36.5M+6.7%	34.2M+2.2%	33.4M+0.1%	33.4M+214%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent	-$24.41M-11.3%	-$21.93M-2.1%	-$21.48M-10.4%	-$19.45M+18.5%	-$23.88M-52.7%
Interest income and other, net	$3.75M+0.4%	$3.73M+61.7%	$2.31M-3.6%	$2.39M-9.6%	$2.65M-12.4%
Other Comprehensive Income (Loss), Reclassification Adjustment from AOCI for Sale of Securities, Net of Tax	——	$13.5K0.0%	$13.5K0.0%	$13.5K0.0%	$13.5K-8.5%
Net unrealized gains (losses) on securities still held	-$892K-580%	$186K+30.1%	$143K+440%	-$42K-2,000%	-$2K-125%
EBIT	-$27.27M-5.7%	-$25.8M-7.8%	-$23.93M-9.7%	-$21.81M+17.8%	-$26.53M-42.6%
EBITDA	-$27.2M-5.7%	-$25.74M-8.0%	-$23.83M-9.8%	-$21.71M+17.9%	-$26.45M-42.6%
EBITDA	-$27.2M-5.7%	-$25.74M-8.0%	-$23.83M-9.8%	-$21.71M+17.9%	-$26.45M-42.6%
EBIT	-$27.27M-5.7%	-$25.8M-7.8%	-$23.93M-9.7%	-$21.81M+17.8%	-$26.53M-42.6%

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Questions, answered.

Where does MBX Biosciences, Inc.'s income statement data come from?: Every line is extracted from MBX Biosciences, Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.